# Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)

> **NCT01595646** · PHASE2 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 37 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment

## Interventions

- **DRUG:** Saline
- **DRUG:** Insulin detemir
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT01595646
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-03-12
- **Final completion:** 2015-03-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595646, "Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 120 Days (SL120)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01595646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*